| Sun Pharma Presents LEQSELVI at the 2024 Fall Clinical Dermatology Conference, | October 25, 2024 |
| WINLEVI poster presentations at 2024 Fall Clinical Dermatology Conference, | October 25, 2024 |
| U.S. FDA Approves LEQSELVI™(deuruxolitinib), and Oral JAK Inhibitor for the Treatment of Severe Alopecia Areata | July 26, 2024 |
| Sun Pharma Completes Taro Merger, | June 24, 2024 |
| Sun Pharma’s GL0034 (Utreglutide) Demonstrates Significant Weight Loss, Gluco-metabolic and Lipid Lowering Efficacy in Individuals with Obesity in Oral Presentation at the American Diabetes Association 84th Scientific Sessions, | June 22, 2024 |
| Press Release Results of the Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024 | May 31, 2024 |
| Taro Shareholders Approve Merger with Sun Pharma | May 23, 2024 |
| Taro Announces Merger Agreement with Sun Pharma, | January 18, 2024 |
